01 1Concord Biotech
01 1MITOMYCIN USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2019-10-21
Pay. Date : 2019-04-24
DMF Number : 33662
Submission : 2019-04-20
Status : Active
Type : II
20
Concord Biotech Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is MITOMYCIN USP, with a corresponding US DMF Number 33662.
Remarkably, this DMF maintains an Active status since its submission on April 20, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 21, 2019, and payment made on April 24, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II
